Showing results (721-730 of 863) with videos related to

Sort By:
Pageof 87
Alzheimer'S Research & Therapy|January 3, 2024
Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey studyLisa Waterink, Larissa A Masselink, Sven J van der Lee, et al.
Psychological Medicine|September 18, 2014
Trajectories of cognitive decline in different types of dementiaL L Smits, A C van Harten, Y A L Pijnenburg, et al.
Trends in Molecular Medicine|August 10, 2015
Stimulating translational research: several European life science institutions put their heads togetherMohamed Bentires-Alj, Abinaya Rajan, Wim van Harten, et al.
Frontiers in Pharmacology|March 25, 2026
Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European regionJulie Vancoppenolle, Nora Franzen, Cristina Andrianò, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 6, 2024
Sensitivity of the Boston criteria version 2.0 in Dutch-type hereditary cerebral amyloid angiopathyRgj van der Zwet, E A Koemans, S Voigt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 16, 2023
Changes in self- and study partner-perceived cognitive functioning in relation to amyloid status and future clinical progression: Findings from the SCIENCe projectMark A Dubbelman, Sietske A M Sikkes, Jarith L Ebenau, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 2, 2023
Plasma-derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms: A community-based studyJanina Krell-Roesch, Isabella Zaniletti, Jeremy A Syrjanen, et al.
Translational Behavioral Medicine|June 7, 2019
From impact factors to real impact: translating evidence on lifestyle interventions into routine mental health careJeroen Deenik, Louise Czosnek, Scott B Teasdale, et al.
JAMA Network Open|December 3, 2025
Longitudinal Blood-Based Biomarkers and Clinical Progression in Subjective Cognitive DeclineCalvin Trieu, Argonde C van Harten, Mardou S S A van Leeuwenstijn, et al.
Scientific Reports|February 13, 2020
Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibitionAnne M van Harten, D Vicky de Boer, Sanne R Martens-de Kemp, et al.
Pageof 87